Cell Banking Outsourcing Market Size, Share, Growth Analysis, By Type(Master Cell Banking and Working Cell Banking), By End-User(Biopharmaceutical Companies and Contract Research Organizations (Cros).), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35D2076 | Region: Global | Published Date: March, 2024
Pages: 219 |Tables: 59 |Figures: 75

Cell Banking Outsourcing Market Insights

Global Cell Banking Outsourcing Market size was valued at USD 10.60 billion in 2022 and is poised to grow from USD 12.34 billion in 2023 to USD 41.58 billion by 2031, growing at a CAGR of 16.40% during the forecast period (2024-2031).

The global cell banking outsourcing market is expected to experience significant growth in the coming years, driven by various factors. One of the major drivers is the rising advancement of cryopreservation and cell bank preparation methodologies. Additionally, the increasing adoption of stem cell therapies and growing demand for monoclonal antibodies and effective biopharmaceuticals contribute to market growth. According to CellTrials.org, global enrollments of new trials in advanced cell therapy increased almost 30% in the first quarter of 2020, indicating a growing demand for cell banking services. Moreover, favorable government initiatives and the introduction of new technology for cell line storage and characterization are expected to further propel market growth. Several key players in the market are involved in research collaborations, which are expected to drive market growth. For instance, in May 2021, Opsis Therapeutics, FUJIFILM Cellular Dynamics, and Blue Rock Therapeutics entered into a strategic research and development collaboration to develop off-the-shelf iPSCs to cure ocular diseases. In March 2022, a study led by the Indiana University School of Medicine found that human-induced pluripotent stem cells can improve visual acuity and vascular health, indicating the potential of stem cell banking in managing the vascular health complications associated with type 2 diabetes. Additionally, research for introducing cry protective agents to preserve tissue stability during cryopreservation is expected to drive market growth.

US Cell Banking Outsourcing Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 10.60 billion

Largest Segment

Master cell banking

Fastest Growth

Master cell banking

Growth Rate

16.40% CAGR

Global Cell Banking Outsourcing Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Cell Banking Outsourcing Market Segmental Analysis

Global Cell Banking Outsourcing market is segmented by type, end-user, and region. Based on type, the market can be segmented into master cell banking, and working cell banking. Based on end-user, the market is segmented into biopharmaceutical companies and contract research organizations (CROs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Cell Banking Outsourcing Market Analysis by Type

By type, the market can be segmented into master cell banking and working cell banking. Master cell banking dominated the market due to the increasing demand for the production of biopharmaceuticals and the development of stable cell lines. Master cell banking involves the creation of large quantities of cells that can be used to produce a wide range of products. The growing demand for monoclonal antibodies and effective biopharmaceuticals is driving the growth of this segment.

The working cell banking segment is expected to witness the fastest growth during the forecast period. Working cell banking involves the storage and maintenance of cells used for the production of specific products. The increasing adoption of stem cell therapies and the development of new cell line storage and characterization technology are driving the segment's growth. Additionally, the introduction of cry protective agents to preserve the stability of tissues during cryopreservation is expected to further drive the growth of the working cell banking segment.

Cell Banking Outsourcing Market Analysis by End-User

By end-user, the market can be segmented into biopharmaceutical companies and contract research organizations (CROs). Biopharmaceutical companies dominate the market due to their large demand for cell banking services. Biopharmaceutical companies require a significant amount of cells to produce biopharmaceuticals, and outsourcing cell banking services can reduce their production costs. The increasing demand for monoclonal antibodies and effective biopharmaceuticals is driving the growth of this segment.

The CROs segment is expected to witness the fastest growth during the forecast period. Contract research organizations provide a range of services to biopharmaceutical companies, including cell banking services. The increasing outsourcing of research activities by biopharmaceutical companies to CROs is driving the growth of this segment. Additionally, the growing trend of virtual drug development is expected to further drive the growth of the CROs segment in the cell banking outsourcing market.

Global Cell Banking Outsourcing Market By Type

To get detailed analysis on other segments, Request For Free Sample Report

Cell Banking Outsourcing Market Regional Insights

North America dominated the market due to the presence of a well-established biopharmaceutical industry and advanced healthcare infrastructure. The growing demand for personalized medicines and increasing research activities in the region are driving the growth of the cell banking outsourcing market. The United States is the largest contributor to the growth of the North American market due to the increasing investments in the research and development of cell-based therapies.

The APAC region is expected to witness the fastest growth during the forecast period. The increasing demand for cell banking services in the region can be attributed to the growing awareness about the potential benefits of stem cell therapy and the increasing investment in research and development activities. Moreover, the growing population, rising prevalence of chronic diseases, and increasing healthcare expenditure are also contributing to the growth of the cell banking outsourcing market in the region.

Global Cell Banking Outsourcing Market By Geography
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Cell Banking Outsourcing Market Dynamics

Cell Banking Outsourcing Market Drivers

Increasing adoption of stem cell therapies

  • One of the major drivers of the global cell banking outsourcing market is the increasing adoption of stem cell therapies. Stem cell therapy is a rapidly growing field of regenerative medicine that has the potential to treat a wide range of diseases and disorders. As the demand for stem cell therapies grows, the need for stable and high-quality cell lines increases, leading to a greater demand for cell banking services. This is driving the growth of the cell banking outsourcing market, as biopharmaceutical companies and CROs seek efficient and cost-effective solutions for producing and storing these valuable cell lines.

Cell Banking Outsourcing Market Restraints

High cost of cell banking services

  • One of the major restraints for the global cell banking outsourcing market is the high cost of cell banking services. The process of cell banking involves extensive testing and characterization to ensure the safety and quality of the cell lines. This requires a significant investment in infrastructure and specialized equipment, which can drive up the cost of the service. In addition, the stringent regulations imposed by regulatory bodies on the production and storage of cell lines can also add to the cost. The high cost of cell banking services may limit the adoption of these services, especially in developing regions with limited healthcare budgets.

Request Free Customization of this report to help us to meet your business objectives.

Cell Banking Outsourcing Market Competitive Landscape

The global cell banking outsourcing market is highly competitive and fragmented, with several small and large players offering a wide range of services. The market players compete based on factors such as service quality, pricing, technology, and customer service. The presence of favorable government initiatives, collaborations, and strategic partnerships are also significant competitive factors in the market. Moreover, market players are focusing on the development of new technologies and services to meet the increasing demand for cell banking services. The intense competition in the market is expected to drive innovation and foster growth in the industry.

Cell Banking Outsourcing Market Top Player’s Company Profiles

  • SGS SA (Switzerland)
  • Eurofins Scientific (Luxembourg)
  • Merck KGaA (Germany)
  • BioReliance Corporation (US)
  • Toxikon Corporation (US)
  • GlobalStem (US)
  • Paragon Bioservices, Inc. (US)
  • BSL Bioservice Scientific Laboratories GmbH (Germany)
  • ATCC (US)
  • BioOutsource Ltd. (UK)
  • ViruSure GmbH (Austria)
  • Sartorius AG (Germany)
  • Thermo Fisher Scientific Inc. (US)
  • Covance Inc. (US)
  • TATAA Biocenter AB (Sweden)
  • CellBank Australia (Australia)
  • StemExpress, LLC (US)

Cell Banking Outsourcing Market Recent Developments

  • In April 2023, BioOutsource Ltd. announced the launch of its new biosimilar characterization service for monoclonal antibodies.
  • In March 2023, Thermo Fisher Scientific Inc. announced the launch of its new Gibco® StemFlex™ Medium for the culture of human pluripotent stem cells.
  • In February 2023, Eurofins Scientific announced the acquisition of Cell Guidance Systems, a leading provider of cell-based assay development services.
  • In January 2023, Sartorius AG announced the acquisition of Sabio Scientific, a leading provider of cell analysis solutions.
  • In November 2022, Merck KGaA announced the launch of its new BioReliance® Gene Therapy and Cell Therapy Testing Facility in Shanghai, China.

Cell Banking Outsourcing Key Market Trends

  • One key trend in the cell banking outsourcing market is the increasing demand for personalized medicine. Personalized medicine aims to provide individualized treatment based on a patient's genetic makeup. This requires the use of cells that are tailored to the specific needs of the patient. Cell banking outsourcing companies are investing in technologies that allow them to produce cells that are genetically matched to the patient. This trend is expected to drive the growth of the market as the demand for personalized medicine continues to increase.

Cell Banking Outsourcing Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our global cell banking outsourcing market analysis, the market is experiencing significant growth, driven by factors such as the increasing adoption of stem cell therapies, the growing demand for monoclonal antibodies and effective biopharmaceuticals, and the rising advancements in cryopreservation and cell bank preparation methodologies. The market is segmented by type into master cell banking and working cell banking, and by end-user into biopharmaceutical companies and contract research organizations. North America dominated the market. Key players in the market are engaging in research collaborations to develop off-the-shelf induced pluripotent stem cells (iPSCs) to cure ocular diseases and manage vascular health complications associated with type 2 diabetes.

Report Metric Details
Market size value in 2022 USD 10.60 billion
Market size value in 2031 USD 41.58 billion
Growth Rate 16.40%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Type
    • Master Cell Banking and Working Cell Banking
  • End-User
    • Biopharmaceutical Companies and Contract Research Organizations (Cros).
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • SGS SA (Switzerland)
  • Eurofins Scientific (Luxembourg)
  • Merck KGaA (Germany)
  • BioReliance Corporation (US)
  • Toxikon Corporation (US)
  • GlobalStem (US)
  • Paragon Bioservices, Inc. (US)
  • BSL Bioservice Scientific Laboratories GmbH (Germany)
  • ATCC (US)
  • BioOutsource Ltd. (UK)
  • ViruSure GmbH (Austria)
  • Sartorius AG (Germany)
  • Thermo Fisher Scientific Inc. (US)
  • Covance Inc. (US)
  • TATAA Biocenter AB (Sweden)
  • CellBank Australia (Australia)
  • StemExpress, LLC (US)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Cell Banking Outsourcing Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Cell Banking Outsourcing Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Cell Banking Outsourcing Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Cell Banking Outsourcing Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Cell Banking Outsourcing Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Cell Banking Outsourcing Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?
REQUEST FREE CUSTOMIZATION

FAQs

Global Cell Banking Outsourcing Market size was valued at USD 10.60 billion in 2022 and is poised to grow from USD 12.34 billion in 2023 to USD 41.58 billion by 2031, growing at a CAGR of 16.40% during the forecast period (2024-2031).

The global cell banking outsourcing market is highly competitive and fragmented, with several small and large players offering a wide range of services. The market players compete based on factors such as service quality, pricing, technology, and customer service. The presence of favorable government initiatives, collaborations, and strategic partnerships are also significant competitive factors in the market. Moreover, market players are focusing on the development of new technologies and services to meet the increasing demand for cell banking services. The intense competition in the market is expected to drive innovation and foster growth in the industry. 'Lonza Group Ltd. (Switzerland)', 'SGS SA (Switzerland)', 'Charles River Laboratories International, Inc. (US)', 'WuXi AppTec (China)', 'Eurofins Scientific (Luxembourg)', 'Merck KGaA (Germany)', 'BioReliance Corporation (US)', 'Toxikon Corporation (US)', 'GlobalStem (US)', 'Paragon Bioservices, Inc. (US)', 'BSL Bioservice Scientific Laboratories GmbH (Germany)', 'ATCC (US)', 'BioOutsource Ltd. (UK)', 'ViruSure GmbH (Austria)', 'Sartorius AG (Germany)', 'Thermo Fisher Scientific Inc. (US)', 'Covance Inc. (US)', 'TATAA Biocenter AB (Sweden)', 'CellBank Australia (Australia)', 'StemExpress, LLC (US)'

One of the major drivers of the global cell banking outsourcing market is the increasing adoption of stem cell therapies. Stem cell therapy is a rapidly growing field of regenerative medicine that has the potential to treat a wide range of diseases and disorders. As the demand for stem cell therapies grows, the need for stable and high-quality cell lines increases, leading to a greater demand for cell banking services. This is driving the growth of the cell banking outsourcing market, as biopharmaceutical companies and CROs seek efficient and cost-effective solutions for producing and storing these valuable cell lines.

One key trend in the cell banking outsourcing market is the increasing demand for personalized medicine. Personalized medicine aims to provide individualized treatment based on a patient's genetic makeup. This requires the use of cells that are tailored to the specific needs of the patient. Cell banking outsourcing companies are investing in technologies that allow them to produce cells that are genetically matched to the patient. This trend is expected to drive the growth of the market as the demand for personalized medicine continues to increase.

North America dominated the market due to the presence of a well-established biopharmaceutical industry and advanced healthcare infrastructure. The growing demand for personalized medicines and increasing research activities in the region are driving the growth of the cell banking outsourcing market. The United States is the largest contributor to the growth of the North American market due to the increasing investments in the research and development of cell-based therapies.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Cell Banking Outsourcing Market

Report ID: SQMIG35D2076

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE